LYCOS RETRIEVER 
Solvay Pharmaceuticals, Inc.
built 179 days ago
Such was the case for Solvay Pharmaceuticals, a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium, but with test facilities in the Netherlands, United States, Germany and Japan. Using SAS Drug Development, Solvay Pharmaceuticals effectively removes geographic boundaries to make information available to anyone who needs it, when they need it.
Source:
In October 2006, Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals announced that a New Drug Application was submitted to the U.S. Food and Drug Administration for bifeprunox, an investigational antipsychotic for the treatment of schizophrenia and for maintenance of stability. Under the terms of a collaboration agreement entered into in March 2004, Solvay Pharmaceuticals and Wyeth Pharmaceuticals agreed to co-develop and co-commercialize bifeprunox and other compounds, which are in earlier stages of development, as potential treatments for schizophrenia and other psychiatric conditions. The original compound was discovered by Solvay Pharmaceuticals and is being developed by Solvay Pharmaceuticals, Lundbeck and Wyeth.
Source:
Solvay Pharmaceuticals, one of the top pharmaceutical companies in the world, focuses drug development efforts in the fields of psychiatry, gastroenterology, cardiology, male and female hormone replacement therapy, and immunology. The company invests 15 percent of sales earnings into research for new drugs.
Source:
Solvay Pharmaceuticals, Inc., which has a long-standing commitment to AFSP and suicide prevention, will ... present its pledge of $1 million toward AFSP's current fundraising campaign. Participating in the briefing will be:
Source:
Solvay Pharmaceuticals, Inc. has acquired the pharmaceutical assets related principally to current estrogen production of Chicago area-based ORGANICS/LaGrange. ORGANICS/LaGrange is the manufacturer of a key active ingredient in Solvay Pharmaceuticals’ ESTRATEST® Tablets.
Source:
MORE ABOUT
Solvay Pharmaceuticals, Inc.